NewEdge Wealth LLC boosted its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 10.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,042 shares of the financial services provider’s stock after acquiring an additional 831 shares during the quarter. NewEdge Wealth LLC’s holdings in CME Group were worth $2,100,000 at the end of the most recent quarter.
Other institutional investors have also added to or reduced their stakes in the company. Meyer Handelman Co. purchased a new position in shares of CME Group during the fourth quarter valued at approximately $6,144,000. Spire Wealth Management grew its position in CME Group by 37.4% in the 4th quarter. Spire Wealth Management now owns 1,320 shares of the financial services provider’s stock worth $307,000 after purchasing an additional 359 shares during the period. AEGON ASSET MANAGEMENT UK Plc grew its position in CME Group by 19.3% in the 4th quarter. AEGON ASSET MANAGEMENT UK Plc now owns 326,098 shares of the financial services provider’s stock worth $75,730,000 after purchasing an additional 52,862 shares during the period. Bank of Montreal Can raised its stake in CME Group by 41.8% during the 3rd quarter. Bank of Montreal Can now owns 1,028,090 shares of the financial services provider’s stock valued at $224,432,000 after buying an additional 303,169 shares during the last quarter. Finally, Geode Capital Management LLC lifted its holdings in shares of CME Group by 1.8% during the 3rd quarter. Geode Capital Management LLC now owns 8,284,745 shares of the financial services provider’s stock valued at $1,823,964,000 after buying an additional 142,692 shares during the period. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several brokerages recently commented on CME. Keefe, Bruyette & Woods lifted their price objective on CME Group from $256.00 to $257.00 and gave the stock a “market perform” rating in a report on Friday, February 14th. Piper Sandler upped their price target on shares of CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. Royal Bank of Canada raised their price objective on shares of CME Group from $235.00 to $269.00 and gave the stock a “sector perform” rating in a report on Thursday, February 13th. JPMorgan Chase & Co. upped their target price on shares of CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a report on Thursday, February 13th. Finally, Morgan Stanley lifted their price target on shares of CME Group from $256.00 to $263.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 19th. Four analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and a consensus price target of $236.13.
Insider Activity at CME Group
In other CME Group news, insider Hilda Harris Piell sold 3,984 shares of CME Group stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $250.47, for a total value of $997,872.48. Following the sale, the insider now owns 27,046 shares of the company’s stock, valued at $6,774,211.62. The trade was a 12.84 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Julie Winkler sold 11,592 shares of the company’s stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total value of $2,888,378.64. Following the sale, the insider now directly owns 21,885 shares in the company, valued at $5,453,085.45. This trade represents a 34.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by corporate insiders.
CME Group Price Performance
Shares of CME Group stock opened at $253.77 on Friday. The company has a market capitalization of $91.45 billion, a price-to-earnings ratio of 26.24, a PEG ratio of 6.76 and a beta of 0.57. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The stock’s 50-day simple moving average is $238.42 and its 200-day simple moving average is $229.07. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $254.40.
CME Group (NASDAQ:CME – Get Free Report) last issued its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. As a group, analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.
CME Group Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Friday, March 7th will be given a dividend of $1.25 per share. This is a positive change from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date is Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.97%. CME Group’s dividend payout ratio is currently 51.71%.
CME Group declared that its Board of Directors has approved a share buyback plan on Thursday, December 5th that allows the company to repurchase $3.00 billion in shares. This repurchase authorization allows the financial services provider to buy up to 3.4% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s management believes its shares are undervalued.
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories
- Five stocks we like better than CME Group
- Golden Cross Stocks: Pattern, Examples and Charts
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- Bank Stocks – Best Bank Stocks to Invest In
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- What Are the U.K. Market Holidays? How to Invest and Trade
- MarketBeat Week in Review – 02/24 – 02/28
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.